We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Nanoparticle Therapy Targets Tumor-Associated Immunosuppressive Cells

By LabMedica International staff writers
Posted on 29 Jul 2009
Print article
Nanoparticles loaded with siRNA (small interfering RNA) were able to destroy ovarian tumors by converting immunosuppressive dendritic cells associated with the tumors into potent immunostimulatory cells that both generated antitumor antibodies and directly attacked the cancer cells.

Investigators at Dartmouth Medical School (Hanover, NH, USA) observed that nanoparticles made from linear polyethylenimine (PEI) and siRNA (siRNA-PEI nanoparticles) were selectively engulfed by tumor-associated immune dendritic cells. In contrast, the cancer cells making up the tumor failed to incorporate the nanoparticles.

Fortunately, the siRNA-PEI nanoparticles caused a dramatic change in the behavior pattern of the tumor-associated dendritic cells. Uptake of nanoparticles transformed these dendritic cells from immunosuppressive cells to efficient antigen-presenting cells that activated tumor-reactive lymphocytes and exerted direct tumoricidal activity. This transformation appeared to be linked to the activation of several different Toll-like receptors.

Nanoparticles loaded with siRNA that inhibited specific immunosuppressive genes gave superior therapeutic results in mice with ovarian cancer than did nanoparticles loaded with nonspecific siRNA.

"We have modulated elements of the tumor microenvironment that are not cancer cells, reversing their role as accomplices in tumor growth to attackers that boost responses against the tumor," said senior author Dr. Jose Conejo-Garcia, assistant professor of microbiology at Dartmouth Medical School. "The cooperating cells hit by the particles return to fighters that immediately kill tumor cells."

"This could be part of a ‘multimodal approach,' against ovarian cancer," said Dr. Conejo-Garcia. "The prevailing treatment is surgical debulking, followed by chemotherapy. Our findings could complement those because they target not the tumor cells themselves, but different cells present around the tumor."

Related Links
Dartmouth Medical School

New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Flu Test
ID NOW Influenza A & B 2
New
CVD Risk Test
GammaCoeur CVD Risk ELISA Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The AI program analyzes a microscopy image from a tumor biopsy and determines what genes are likely turned on and off in the cells it contains (Photo courtesy of Olivier Gevaert/Stanford Medicine)

AI Tool ‘Sees’ Cancer Gene Signatures in Biopsy Images

To assess the type and severity of cancer, pathologists typically examine thin slices of a tumor biopsy under a microscope. However, to understand the genomic alterations driving the tumor's growth, scientists... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.